Weight Loss :: Simple solutions to postpartum weight retention
Women aiming to shed after-pregnancy pounds should add daily walks and limit TV time and trans fats, according to a new study by Harvard researchers.
Women aiming to shed after-pregnancy pounds should add daily walks and limit TV time and trans fats, according to a new study by Harvard researchers.
Drinking whole fat milk and eating ice cream appears to be better for women trying to become pregnant than a diet consisting of low-fat dairy products such as skim milk and yogurt, according to new research published in Human Reproduction journal.
An independent United Nations rights expert denounced a campaign by Filipino milk companies to promote breast-milk substitutes for manipulating UN data to protect their huge profits regardless of the interest of a country where 16,000 children under 5 died in 2003 from improper feeding practices including infant formula.
A 2,000-calorie appetizer. A 2,000-calorie main course. Another 1,700 calories for dessert. Those aren?t typos. It?s more like par for the course at Ruby Tuesday, On the Border, the Cheesecake Factory, and countless other top table-service chain restaurants.
Television advertising in the United Kingdom for foods high in fat, salt, or sugar will be reduced by up to 50 percent on programs viewed by children under 16 under tough new regulations promulgated by Ofcom, that country?s quasi-governmental telecommunications regulator.
Cans and bottles of Pepsi will now bear an important disclosure?the exact amount of caffeine in each serving.
Several public health authorities have issued recommendations or policies aimed at improving the folic acid intake among women of childbearing age.
University of Delaware researchers have developed an inexpensive, nonchlorine-based technology that can remove harmful microorganisms, including viruses, from drinking water.
Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ondansetron Orally Disintegrating Tablets USP, 4mg and 8mg strengths.
Novartis announced that it has received an “approvable letter” from the US Food and Drug Administration (FDA) for Galvus? (vildagliptin), under review for US approval as a new once-daily oral treatment for patients with type 2 diabetes.